KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Inventory Average (2016 - 2025)

Pacific Biosciences Of California has reported Inventory Average over the past 15 years, most recently at $51.2 million for Q4 2025.

  • Quarterly results put Inventory Average at $51.2 million for Q4 2025, down 17.72% from a year ago — trailing twelve months through Dec 2025 was $51.2 million (down 17.72% YoY), and the annual figure for FY2025 was $54.0 million, down 6.4%.
  • Inventory Average for Q4 2025 was $51.2 million at Pacific Biosciences Of California, down from $53.5 million in the prior quarter.
  • Over the last five years, Inventory Average for PACB hit a ceiling of $68.0 million in Q2 2024 and a floor of $15.2 million in Q1 2021.
  • Median Inventory Average over the past 5 years was $55.0 million (2023), compared with a mean of $50.3 million.
  • Biggest five-year swings in Inventory Average: skyrocketed 107.17% in 2023 and later dropped 20.66% in 2025.
  • Pacific Biosciences Of California's Inventory Average stood at $17.1 million in 2021, then soared by 174.07% to $46.9 million in 2022, then skyrocketed by 33.08% to $62.5 million in 2023, then dropped by 0.35% to $62.2 million in 2024, then fell by 17.72% to $51.2 million in 2025.
  • The last three reported values for Inventory Average were $51.2 million (Q4 2025), $53.5 million (Q3 2025), and $53.9 million (Q2 2025) per Business Quant data.